abstract |
The invention relates to use of A1 and/or dual A1/A2b agonists of formula (IA) and (IB) for production of a medicament for treatment of dyslipidemia, metabolic syndrome and diabetes and dyslipidemia, metabolic syndrome and diabetes in connection with hypertonia and diseases of the cardiovascular system. |